AlzBiomarker
MCI-AD vs MCI-Stable: tau-total (Plasma and Serum)
Baseline levels of tau protein in plasma were somewhat higher in people with mild cognitive impairment who went on to develop Alzheimer’s dementia than in those who did not decline at follow-up (effect size =1.364, p = 0.015). However, the p value was only marginally signficant, and only three studies contributed to the meta-analysis.
Loading data...